Stimulation of the Efferent Loop Before Loop Ileostomy Closure
NCT ID: NCT03424447
Last Updated: 2018-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
140 participants
INTERVENTIONAL
2014-11-20
2018-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Protective Role of GABA Stimulation Before Ileostomy Closure
NCT05905393
Feasibility and Safety of an Ileus Management Protocol for Postoperative Ileus After Abdominal Surgery
NCT07194525
Nasogastric Tube Clamping Trial vs. Immediate Removal
NCT04001985
Lap Adhesiolysis in Intestinal Obstruction
NCT06446440
Validation of a Totally Synthetic High Fidelity Laparoscopic Duodenal Atresia (DA) Surgical Simulator
NCT04114279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non stimulated
Prospective data obtained from non stimulated patients
No interventions assigned to this group
Stimulated
Prospective data obtaied from stimulated patients
efferent limb stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
efferent limb stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Barium transit throught the efferent limb without leaks
Exclusion Criteria
* Ileostomy closure at the same admission than the ileostomy creation
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alberto Loizate Totoricaguena
UNKNOWN
Pedro García Alonso
UNKNOWN
Hospital de Basurto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ALBA VÁZQUEZ-MELERO
General Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alba Vázquez-Melero
Role: PRINCIPAL_INVESTIGATOR
general surgeon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Basurto
Bilbao, Vizcaya, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hospital de Basurto
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.